Evidence map›Paper›PMID 33150176›Full record

ArticleBioMed research international2020

Assessment of the Antibacterial Effects of Bismuth Nanoparticles against

Azita Azad, Sahar Rostamifar, Farzan Modaresi, Ali Bazrafkan, Zahra Rezaie

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Synthesize of BiScientific reports · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Azita AzadOral and Dental Disease Research Center, Department of Oral & Maxillofacial Medicine, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0002-1073-4134
Sahar RostamifarStudent Research Committee, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0002-3509-2916
Farzan ModaresiDepartments of Microbiology, Advanced Medical Sciences and Technology, And Central Laboratory Research, Jahrom University of Medical Sciences, Jahrom, Iran.ORCID https://orcid.org/0000-0001-6253-7629
Ali BazrafkanStudent Research Committee, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0001-7110-3785
Zahra RezaieStudent Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.ORCID https://orcid.org/0000-0001-8820-8006
Shiraz University of Medical Sciences · IRJahrom University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction

methodsForty patients, referred to Endodontic Ward of Shiraz University of Medical Science for endodontic pretreatment, provided root canal samples. First, all samples were transferred in Enterococcosel broth and incubated. Then, samples which showed growth were plated on blood agar plates and incubated for further PCR procedure. Nanoparticle powder was dissolved in high-purity water, and the final concentration of bismuth nanoparticles (BiNPs) was measured by the spectrophotometer. Minimum inhibitory concentration (MIC) of BiNPs against

resultsOf all samples, 77.5% revealed the presence of

conclusionThe experimental data suggest that bismuth nanoparticles could be an interesting alternative to combat

Indexed as

AdolescentAdultAnti-Bacterial AgentsBismuthChlorhexidineDental Pulp CavityEnterococcus faecalisFemaleGram-Positive Bacterial InfectionsHumansMaleMetal NanoparticlesMicrobial Sensitivity TestsMiddle AgedRoot Canal TherapyAnti-Bacterial AgentsBismuthChlorhexidine

Identifiers

PMID33150176
PMCPMC7603547
OpenAlexW3093535910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.